Artemis Medicare Services Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Artemis Medicare Services Ltd is ₹ 292.2 as of 30 Oct 15:30 . The P/E Ratio of Artemis Medicare Services Ltd changed from 45.3 on March 2021 to 31.3 on March 2026 . This represents a CAGR of -5.98% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Artemis Medicare Services Ltd changed from ₹ 293.88 crore on March 2021 to ₹ 3249 crore on March 2026 . This represents a CAGR of 49.26% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Artemis Medicare Services Ltd for the Sep '26 is ₹ 319.12 crore as compare to the Jun '26 revenue of ₹ 292.7 crore. This represent the growth of 9.03% The revenue of Syngene International Ltd for the Sep '26 is ₹ 860.7 crore as compare to the Jun '26 revenue of ₹ 761.3 crore. This represent the growth of 13.06% The ebitda of Artemis Medicare Services Ltd for the Sep '26 is ₹ 62.89 crore as compare to the Jun '26 ebitda of ₹ 61.82 crore. This represent the growth of 1.73% The ebitda of Syngene International Ltd for the Sep '26 is ₹ 168.7 crore as compare to the Jun '26 ebitda of ₹ 102.6 crore. This represent the growth of 64.42% The net profit of Artemis Medicare Services Ltd changed from ₹ 16.52 crore to ₹ 31.1 crore over 10 quarters. This represents a CAGR of 28.80% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ 32.2 crore over 10 quarters. This represents a CAGR of -28.96% The Dividend Payout of Artemis Medicare Services Ltd changed from 15.2 % on March 2023 to 6.89 % on March 2026 . This represents a CAGR of -17.95% over 4 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Artemis Medicare Services Ltd

Artemis Medicare Services Limited was incorporated on May 18, 2004.
It commenced the commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on July 16, 2007.
The Company is the holding Company of Artemis Cardiac Care Private Limited and a Subsidiary of Constructive Finance Private Limited.
At present, the Company is engaged in managing and operating of multi specialty hospitals.
Artemis Hospital (a unit of Artemis Medicare Services Limited) is spread across 9 acres, is a 395 bed; state-of-the-art multispeciality hospital located in Gurugram, India. Artemis Health Institute is a healthcare venture launched by the Promoters of the Apollo Tyres Group.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5641 scientists and its state-of-the-art facilities, spread over 2.5 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Artemis Medicare Services Ltd and Syngene International Ltd

Which company has a larger market capitalization, Artemis Medicare Services Ltd or Syngene International Ltd?

Market cap of Artemis Medicare Services Ltd is 4,625 Cr while Market cap of Syngene International Ltd is 16,251 Cr

What are the key factors driving the stock performance of Artemis Medicare Services Ltd and Syngene International Ltd?

The stock performance of Artemis Medicare Services Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Artemis Medicare Services Ltd and Syngene International Ltd?

As of October 31, 2026, the Artemis Medicare Services Ltd stock price is INR ₹292.2. On the other hand, Syngene International Ltd stock price is INR ₹402.6.

How do dividend payouts of Artemis Medicare Services Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Artemis Medicare Services Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.